top of page

Developing Novel Cyclic Peptides to Combat Life – Threatening Infectious Diseases

Our Mission
AJK Biopharmaceutical is developing new classes of peptide-based drugs to treat the world’s most challenging infectious diseases. New antimicrobial drugs are needed to meet the urgent public health threat of antimicrobial resistance.
keyword
Clinical Development of Novel Anti-Infective Drugs



bottom of page